Publications
5543 Results
- Journal / Conference
- Blood Advances Jun 30;bloodadvances.2023010223. doi: 10.1182/bloodadvances.2023010223. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID37389844
- Study Number(s)
- CTSU/9177
Prognostic Factors for Adult Burkitt Lymphoma Patients Treated with Dose-Adjusted EPOCH-R
- Journal / Conference
- Clin Cancer Res Aug 2;CCR-23-0917. doi: 10.1158/1078-0432.CCR-23-0917. Online ahead of print, 2023
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID: 37531248
- PMC
- PMC10690084
The new NCI precision medicine Trials
- Journal / Conference
- Blood Adv. Oct 10;7(19):5941-5953
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37267439
- PMC
- PMC10562769
- Study Number(s)
- S0106
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis
- Journal / Conference
- JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Jul 18:S0022-5223(23)00612-8
- Year
- 2023
- Research Committee(s)
- Lung
- PMID
- PMID37473998
- PMC
- In Process at NIHMS NIHMS1919951
Lobectomy, segmentectomy or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: a post-hoc analysis of CALGB 140503 (Alliance)
- Journal / Conference
- J Clin Oncol. Apr 10;41(11):2076-2086
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID36495588
- PMC
- PMC10082254
- Study Number(s)
- S0816
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium
- Journal / Conference
- Nature Medicine Sep;29(9):2278-2285
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID37592104
- PMC
- PMCID10708907
- Study Number(s)
- S1616
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
- Journal / Conference
- JAMA Oncology Oct 1;9(10):1371-1379
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37590003
- PMC
- PMC10436183
The Medicaid Expansion of the Affordable Care Act and the Participation of Patients with Medicaid in Cancer Clinical Trials
- Journal / Conference
- European Urology Aug 16;S0302-2838(23)03019-1. doi: 10.1016/j.eururo.2023.08.004. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37596191
- PMC
- PMC10869634
- Study Number(s)
- S1605
Phase II Trial of Atezolizumab in BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer: SWOG S1605
- Journal / Conference
- JAMA Netw Open Aug 1;6(8):e2326546
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37526936
- PMC
- PMC10394570
- Study Number(s)
- S1216
Impact of race on treatment outcomes of patients with metastatic castration-sensitive prostate cancer receiving intensified androgen deprivation therapy: A post hoc analysis of the SWOG 1216 phase III trial
- Journal / Conference
- JNCI Cancer Spectrum Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37561111
- PMC
- PMC10471524
- Study Number(s)
- S1912CD